Promising Advances in NEC Research and Treatment
NETCast
00:00
Innovations in Treating Platinum Refractory Lung Cancer
This chapter explores the complexities of treating platinum refractory small cell lung cancer and introduces tarlatumab as a potentially groundbreaking T-cell engager. It highlights ongoing research and clinical trials that investigate innovative therapies, including immunotherapies and novel combinations, aimed at improving patient outcomes.
Transcript
Play full episode
